Clinical trial
Stem Cell Mobilization and VEGF Gene Transfer for Heart Failure
NCT00279539 · Losordo, Douglas, M.D., Other · Withdrawn
Key facts
| NCT number | NCT00279539 |
|---|---|
| Title | Stem Cell Mobilization and VEGF Gene Transfer for Heart Failure |
| Official title | phVEGF165 GENE TRANSFER TO PROMOTE ANGIOGENESIS IN PATIENTS WITH ISCHEMIC HEART FAILURE |
| Lead sponsor | Losordo, Douglas, M.D., Other |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Ischemic Congestive Heart Failure (CHF) |
| Intervention type | Genetic |
| Interventions | Vascular Endothelial Growth Factor (VEGF1) |
| Enrollment | 0 |
| Start date | Jul 1, 2008 |
| First posted | Jan 19, 2006 |
| Last update posted | Apr 1, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: